Gregory L. Damhorst, MD, PhD

Recent Publications

  1. Wilber E, Piantadosi A, Babiker A, McLendon K, O'Sick W, Fitts E, Webster AS, Verkerke H, Kim JS, Phadke VK, Rouphael N, Titanji BK, Blake WT, Howard-Anderson J, Roback JD, Lam WA*, Damhorst GL*. Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19. Open Forum Infect Dis. 2022 Aug 17;9(8):ofac419. doi: 10.1093/ofid/ofac419. PMID: 36043176; PMCID: PMC9416058.

  2. Verkerke HP*, Damhorst GL*, Graciaa DS, McLendon K, O'Sick W, Robichaux C, Cheedarla N, Potlapalli S, Wu SC, Harrington KRV, Webster A, Kraft C, Rostad CA, Waggoner JJ, Gandhi NR, Guarner J, Auld SC, Neish A, Roback JD, Lam WA, Shah NS, Stowell SR. Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection. J Infect Dis. 2022 Jul 25:jiac225. doi: 10.1093/infdis/jiac225. Epub ahead of print. PMID: 35877413.

  3. Farmer S, Razin V, Peagler AF, Strickler S, Fain WB, Damhorst GL, Kempker RR, Pollock NR, Brand O, Seitter B, Heilman SS, Nehl EJ, Levy JM, Gottfried DS, Martin GS, Greenleaf M, Ku DN, Waggoner JJ, Iffrig E, Mannino R, Wang YF, Ortlund E, Sullivan J, Rebolledo PA, Clavería V, Roback JD, Benoit M, Stone C, Esper A, Frank F, Lam WA. Don't Forget About Human Factors: Lessons Learned from COVID-19 Point-of-Care Testing. Cell Rep Methods. 2022 May 3:100222. doi: 10.1016/j.crmeth.2022.100222. Epub ahead of print. PMID: 35527805; PMCID: PMC9061138.

  4. Greenleaf MN, Damhorst GL, Ku DN, Nehl EJ, Tyburski EA, Brand O, Martin GS, Lam WA. Designing for simplicity: lessons from Mesa Biotech for microfluidic entrepreneurs and early-stage companies. Lab Chip. 2022 Apr 12;22(8):1469-1473. doi: 10.1039/d2lc00081d. PMID: 35342919; PMCID: PMC9012986.

  5. Damhorst GL, Watts A, Hernandez-Romieu A, Mel N, Palmore M, Ali IKM, Neill SG, Kalapila A, Cope JR. Acanthamoeba castellanii encephalitis in a patient with AIDS: a case report and literature review. Lancet Infect Dis. 2022 Feb;22(2):e59-e65. doi: 10.1016/S1473-3099(20)30933-6. Epub 2021 Aug 27. PMID: 34461057.

  6. Damhorst GL, Broder KJ, Overton EC, Rara R, Busch LM, Burd EM, Webster AS, Kraft CS, Babiker A. Clinical Utilization of DiaSorin Molecular Polymerase Chain Reaction in Pneumocystis Pneumonia. Open Forum Infect Dis. 2022 Jan 10;9(1):ofab634. doi: 10.1093/ofid/ofab634. PMID: 35036467; PMCID: PMC8754379.

  7. Taneja I*, Damhorst GL*, Lopez-Espina C, Zhao SD, Zhu R, Khan S, White K, Kumar J, Vincent A, Yeh L, Majdizadeh S, Weir W, Isbell S, Skinner J, Devanand M, Azharuddin S, Meenakshisundaram R, Upadhyay R, Syed A, Bauman T, Devito J, Heinzmann C, Podolej G, Shen L, Timilsina SS, Quinlan L, Manafirasi S, Valera E, Reddy B Jr, Bashir R. Diagnostic and prognostic capabilities of a biomarker and EMR-based machine learning algorithm for sepsis. Clin Transl Sci. 2021 Jul;14(4):1578-1589. doi: 10.1111/cts.13030. Epub 2021 May 2. PMID: 33786999; PMCID: PMC8301583.

  8. Damhorst GL, Adelman MW, Woodworth MH, Kraft CS. Current Capabilities of Gut Microbiome-Based Diagnostics and the Promise of Clinical Application. J Infect Dis. 2021 Jun 16;223(12 Suppl 2):S270-S275. doi: 10.1093/infdis/jiaa689. PMID: 33330938; PMCID: PMC8206793.

*Shared first/last author

See all publications